Role of surgery in patients with focally progressive gastrointestinal stromal tumors resistant to imatinib

The benefits of surgery for focally progressive gastrointestinal stromal tumor (GIST) during imatinib therapy are still in discussion. The aim of this study was to compare the outcomes of surgical resection of progressive lesions following tyrosine kinase inhibitor (TKI) therapy (S group) or TKI the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xiaodong, Xue, Anwei, Fang, Yong, Shu, Ping, Ling, Jiaqian, Qin, Jing, Hou, Yingyong, Shen, Kuntang, Sun, Yihong, Qin, Xinyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780000/
https://www.ncbi.nlm.nih.gov/pubmed/26946961
http://dx.doi.org/10.1038/srep22840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780000/
https://www.ncbi.nlm.nih.gov/pubmed/26946961
http://dx.doi.org/10.1038/srep22840

Ejemplares similares